Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Allergan plc    AGN   IE00BY9D5467

ALLERGAN PLC

(AGN)
  Report
Delayed Quote. Delayed Nyse - 04/07 04:10:00 pm
178.26 USD   +0.06%
04/07DAVIDSON KEMPNER CAPITAL MANAGEMENT LP DAVIDSON KEMPNER CAPITAL MANAGEMENT LP : Form 8.3 - Allergan Plc
DJ
04/07ALLERGAN : Form 8.3 - -2-
DJ
04/07ALLERGAN : Form 8.3 -
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Allergan : Form 8.3 -

share with twitter share with LinkedIn share with facebook
share via e-mail
03/26/2020 | 10:56am EDT
TIDM0Y7T TIDM0QCV 
 
 
 
   FORM 8.3 
 
   IRISH TAKEOVER PANEL 
 
   DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, 
TAKEOVER RULES, 2013 
 
   DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 
1% OR MORE 
 
   1. KEY INFORMATION 
 
 
 
 
Name of person dealing (Note 1)                State Street Global Advisors & 
                                               Affiliates 
---------------------------------------------  ------------------------------- 
Company dealt in                               Allergan plc 
---------------------------------------------  ------------------------------- 
Class of relevant security to which            US$0.0001 ordinary shares 
 the dealings being disclosed relate (Note 2) 
---------------------------------------------  ------------------------------- 
Date of dealing                                25(th) March 2020 
---------------------------------------------  ------------------------------- 
 
 
 
   2. INTERESTS AND SHORT POSITIONS 
 
   (a) Interests and short positions (following dealing) in the class of 
relevant security dealt in (Note 3) 
 
 
 
 
                                               Long             Short 
-------------------------------------  --------------------  ----------- 
                                         Number      (%)     Number  (%) 
-------------------------------------  ----------  --------  ------  --- 
(1) Relevant securities                13,653,637  4.14787% 
-------------------------------------  ----------  --------  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------  ----------  --------  ------  --- 
(3) Options and agreements to 
 purchase/sell                                N/A 
-------------------------------------  ----------  --------  ------  --- 
Total                                  13,653,637  4.14787% 
-------------------------------------  ----------  --------  ------  --- 
 
 
   (b) Interests and short positions in relevant securities of the company, 
other than the class dealt in (Note 3) 
 
 
 
 
Class of relevant security:                     Long         Short 
-------------------------------------------  -----------  ----------- 
                                             Number  (%)  Number  (%) 
-------------------------------------------  ------  ---  ------  --- 
(1) Relevant securities                       N/A 
-------------------------------------------  ------  ---  ------  --- 
(2) Derivatives (other than options)          N/A 
-------------------------------------------  ------  ---  ------  --- 
(3) Options and agreements to purchase/sell   N/A 
-------------------------------------------  ------  ---  ------  --- 
Total                                         N/A 
-------------------------------------------  ------  ---  ------  --- 
 
 
   3. DEALINGS (Note 4) 
 
   (a) Purchases and sales 
 
 
 
 
Purchase/sale   Number of relevant securities  Price per unit (Note 5) 
--------------  -----------------------------  ----------------------- 
   Purchase                            13,800                   171.31 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,200                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                             4,800                   168.76 
--------------  -----------------------------  ----------------------- 
   Purchase                               300                   168.66 
--------------  -----------------------------  ----------------------- 
   Purchase                               900                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,778                   171.61 
--------------  -----------------------------  ----------------------- 
   Purchase                                45                   168.87 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,970                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                             1,800                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                               851                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                               100                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,800                   171.30 
--------------  -----------------------------  ----------------------- 
   Purchase                             3,100                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                               176                   169.00 
--------------  -----------------------------  ----------------------- 
   Purchase                                55                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                 300                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                  41                   170.35 
--------------  -----------------------------  ----------------------- 
     Sale                               3,600                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                              21,800                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                               4,728                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                 441                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                  88                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                               4,088                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                  70                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                 100                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                                 118                   169.00 
--------------  -----------------------------  ----------------------- 
     Sale                               6,600                   168.84 
--------------  -----------------------------  ----------------------- 
 
 
 
 
 
   (b) Derivatives transactions (other than options transactions) 
 
 
 
 
Product name,  Nature of transaction  Number of relevant securities  Price per unit 
 e.g. CFD       (Note 6)               (Note 7)                       (Note 5) 
-------------  ---------------------  -----------------------------  -------------- 
N/A 
-------------  ---------------------  -----------------------------  -------------- 
 
 
 
   (c) Options transactions in respect of existing relevant securities 
 
   (i) Writing, selling, purchasing or varying 
 
 
 
 
Product name,      Writing, selling,  Number of             Exercise  Type, e.g.      Expiry  Option money 
 e.g. call option   purchasing         securities to which   price     American,       date    paid/received 
                    varying etc.       the option relates              European etc.           per unit (Note 5) 
                                       (Note 7) 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
N/A 
-----------------  -----------------  --------------------  --------  --------------  ------  ------------------ 
 
 
   (ii) Exercising 
 
 
 
 
Product name,      Number of securities  Exercise price per 
 e.g. call option                           unit (Note 5) 
-----------------  --------------------  ------------------ 
N/A 
-----------------  --------------------  ------------------ 
 
 
   (d) Other dealings (including transactions in respect of new securities) 
(Note 4) 
 
 
 
 
Nature of transaction  Details       Price per unit 
 (Note 8)                        (if applicable) (Note 5) 
---------------------  -------  ------------------------- 
N/A 
---------------------  -------  ------------------------- 
 
 
   4. OTHER INFORMATION 
 
   Agreements, arrangements or understandings relating to options or 
derivatives 
 
 
 
 
Full details of any agreement, arrangement or understanding 
 between the person disclosing and any other person 
 relating to the voting rights of any relevant securities 
 under any option referred to on this form or relating 
 to the voting rights or future acquisition or disposal 
 of any relevant securities to which any derivative 
 referred to on this form is referenced. If none, this 
 should be stated. 
----------------------------------------------------------- 
N/A 
----------------------------------------------------------- 
 
 
 
 
 
 
Is a Supplemental Form 8 attached? (Note 9)                     NO 
-------------------------------------------------------  ----------------- 
Date of disclosure                                       26(th) March 2020 
-------------------------------------------------------  ----------------- 
Contact name                                               Lionel Colaco 
-------------------------------------------------------  ----------------- 
Telephone number                                              020 33956098 
-------------------------------------------------------  ----------------- 
If a connected EFM, name of offeree/offeror with which   N/A 
 connected 

(MORE TO FOLLOW) Dow Jones Newswires

03-26-20 1155ET

This article is part of a news chaine.
Article 1 / 2
<< Preceding Next >>
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on ALLERGAN PLC
04/07DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
04/07ALLERGAN : Form 8.3 - -2-
DJ
04/07ALLERGAN : Form 8.3 -
DJ
04/06ALLERGAN : Form 8.3 - -2-
DJ
04/06ABBVIE : Form 8.3 -
DJ
04/06DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
04/03DAVIDSON KEMPNER CAPITAL MANAGEMENT : Form 8.3 - Allergan Plc
DJ
04/03ALLERGAN : Form 8.3 -
DJ
04/02ABBVIE : Form 8.3 -
AQ
04/02ALLERGAN : Form 8.3 - -2-
DJ
More news
Financials (USD)
Sales 2020 15 713 M
EBIT 2020 7 085 M
Net income 2020 192 M
Debt 2020 12 765 M
Yield 2020 1,67%
P/E ratio 2020 118x
P/E ratio 2021 44,0x
EV / Sales2020 4,54x
EV / Sales2021 4,13x
Capitalization 58 648 M
Chart ALLERGAN PLC
Duration : Period :
Allergan plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALLERGAN PLC
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 17
Average target price 193,50  $
Last Close Price 178,26  $
Spread / Highest target 43,0%
Spread / Average Target 8,55%
Spread / Lowest Target -11,9%
EPS Revisions
Managers
NameTitle
Brenton L. Saunders Chairman, President & Chief Executive Officer
Wayne R. Swanton Executive Vice President-Global Operations
Matthew M. Walsh Chief Financial Officer & Executive Vice President
C. David Nicholson Chief Research & Development Officer & EVP
Charles Hugh-Jones Chief Medical Officer
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN PLC-6.75%58 648
JOHNSON & JOHNSON-4.19%362 446
ROCHE HOLDING AG0.67%277 253
MERCK & CO., INC-13.62%198 371
NOVARTIS-9.90%193 214
PFIZER, INC.-14.22%186 456